VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CBIO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CBIOCrescent Biopharma, Inc.
$18.26$503M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCBIOQuarterly Balance Sheet

Crescent Biopharma, Inc. (CBIO) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

Crescent Biopharma, Inc. (CBIO) quarterly balance sheet — complete assets, liabilities & equity history

CBIO Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Total Current Assets195.56M236.66M134.56M154.23M5.99M11.09M15.65M23.86M33.27M43.79M52.01M60.37M
Cash & Short-Term Investments189.16M213.19M133.26M152.65M5.61M10.72M14.39M22.39M31.28M41.79M49.41M58.04M
Cash Only189.16M213.19M133.26M152.65M5.61M10.72M14.39M22.39M31.28M41.79M49.41M58.04M
Short-Term Investments000000000000
Accounts Receivable018M000136.58K50.26K76.71K109.95K175.82K188.95K215.37K
Days Sales Outstanding-152.71-------1.68K--
Inventory000000000000
Days Inventory Outstanding------------
Other Current Assets6.4M5.46M1.3M1.58M78.76K0000000
Total Non-Current Assets3.57M3.64M3.71M3.21M0052.32K561.31K937.52K1.53M1.19M1.45M
Property, Plant & Equipment2.3M2.31M2.35M1.8M000424.21K598.26K767.83K1.09M1.35M
Fixed Asset Turnover0.45x4.65x-------0.01x--
Goodwill000000000000
Intangible Assets004.85M000000000
Long-Term Investments00107K106K00000000
Other Non-Current Assets1.27M1.32M-3.59M1.3M0052.32K137.1K339.26K757.91K102.32K102.32K
Total Assets199.13M240.29M138.27M157.43M5.99M11.09M15.7M24.42M34.2M45.32M53.2M61.82M
Asset Turnover0.00x0.06x-------0.00x--
Asset Growth %3223.16%2066.47%780.8%544.72%-82.48%-75.52%-70.49%-60.5%-50.37%-12.53%-4.93%-4.95%
Total Current Liabilities14.19M36.07M20.3M16.75M2.62M5.78M4.32M4.36M5.29M6.84M6.39M6.57M
Accounts Payable1.19M10M2.56M1.65M148.26K1.38M1.01M950.76K755.53K868.12K329.88K241.49K
Days Payables Outstanding------------
Short-Term Debt453K435K417K211K00000000
Deferred Revenue (Current)3.12M4.16M0000000000
Other Current Liabilities9.43M21.48M17.33M9.7M1.68M3.49M1.82M545.55K1.23M2.96M2.4M2.57M
Current Ratio13.78x6.56x6.63x9.21x2.29x1.92x3.62x5.48x6.28x6.41x8.14x9.19x
Quick Ratio13.78x6.56x6.63x9.21x2.29x1.92x3.62x5.48x6.28x6.41x8.14x9.19x
Cash Conversion Cycle------------
Total Non-Current Liabilities1.09M1.21M1.32M1.43M0000066.84K262.13K448.77K
Long-Term Debt1.09M1.21M1.32M1.43M00000000
Capital Lease Obligations001.32M1.43M0000066.84K262.13K448.77K
Deferred Tax Liabilities000000000000
Other Non-Current Liabilities00-1.32M-1.43M00000000
Total Liabilities15.28M37.28M21.63M18.18M2.62M5.78M4.32M4.36M5.29M6.9M6.65M7.02M
Total Debt1.54M1.64M3.06M3.08M066.84K262.13K448.77K630.83K808.4K1.01M1.27M
Net Debt-187.62M-211.55M-130.2M-149.57M-5.61M-10.65M-14.13M-21.94M-30.65M-40.98M-48.4M-56.77M
Debt / Equity0.01x0.01x0.03x0.02x-0.01x0.02x0.02x0.02x0.02x0.02x0.02x
Debt / EBITDA------------
Net Debt / EBITDA------------
Interest Coverage----19.31x-12.62x-19.97x------
Total Equity183.85M203.01M116.64M139.25M3.38M5.31M11.38M20.06M28.91M38.41M46.55M54.8M
Equity Growth %5346.91%3720.64%925.3%594.1%-88.33%-86.17%-75.56%-63.39%-53.51%-10.52%-3.26%-1.66%
Book Value per Share6.0510.067.0536.100.170.270.180.310.450.600.720.85
Total Shareholders' Equity183.85M203.01M116.64M139.25M3.38M5.31M11.38M20.06M28.91M38.41M46.55M54.8M
Common Stock28K28K14K14K64.53K64.48K64.48K64.48K64.45K64.39K64.37K64.31K
Retained Earnings-195.09M-171.81M-79.41M-54.8M-496.71M-494.36M-487.14M-477.32M-467.22M-456.49M-447.41M-438.2M
Treasury Stock000000000000
Accumulated OCI000000000000
Minority Interest000000000000